首页> 外文期刊>Retinal cases & brief reports >BILATERAL ORBITAL VASCULATURE ALTERATIONS AFTER SYSTEMIC CHEMOTHERAPY AND EXTERNAL BE; RADIATION THERAPY TREATMENT C ADVANCED RETINOBLASTOMA: IMPLICATIONS FOR INTRAARTERIAL CHEMOTHERAPY MANAGEMENT
【24h】

BILATERAL ORBITAL VASCULATURE ALTERATIONS AFTER SYSTEMIC CHEMOTHERAPY AND EXTERNAL BE; RADIATION THERAPY TREATMENT C ADVANCED RETINOBLASTOMA: IMPLICATIONS FOR INTRAARTERIAL CHEMOTHERAPY MANAGEMENT

机译:系统性化疗后和外部BE后的双眼眶静脉改变;放射疗法治疗高级视网膜母细胞瘤:对动脉内化疗的管理意义

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose: The purpose of this study was to report significant alterations in orbital vasculature after combined systemic chemoreduction with consolidating external beam radiotherapy treatment in a case of advanced retinoblastoma and to discuss implications for intraarterial melphalan rescue chemotherapy.Methods: We studied the case of a 22-month-old child who had been treated recently with intraarterial melphalan perfusion after multimodal therapy for advanced intraocular retinoblastoma.Results: Orbital angiography of both eyes, performed before the intraarterial melphalan injection, documented an atypical attenuated orbital vasculature. The right ophthalmic artery angiogram showed loss of a normal dominant central retinal artery. Instead, multiple dysplastic angiogenic vessels from the ophthalmic artery were found to supply the retina. A single long ciliary artery was noted with collateral vessels supplying the anterior globe. The left ophthalmic artery angiogram showed a stenotic artery with minimal anterograde flow.Conclusion: Orbital vasculature may be impacted by combined systemic chemotherapy and external beam radiation therapy. These changes need to be considered in the use of intraarterial melphalan for the treatment of patients with advanced retinoblastoma.
机译:目的:本研究的目的是报告在晚期视网膜母细胞瘤患者中,系统化学还原联合外照射放疗联合治疗后眼眶脉管系统的显着改变,并探讨其对动脉内美法仑抢救化疗的意义。方法:我们研究了22例情况个月大的儿童,在多模式治疗晚期眼内视网膜母细胞瘤后接受了近期的动脉内美法仑灌注治疗。右眼动脉造影显示正常的中央视网膜中央动脉丢失。取而代之的是,发现来自眼动脉的多个增生性血管生成血管供应视网膜。注意到有一条长长的睫状动脉,其侧支血管供应前球。左眼动脉造影显示狭窄动脉的顺行血流较少。结论:全身化疗联合外照射治疗可能会影响眼眶血管。在使用动脉注射美法仑治疗晚期视网膜母细胞瘤患者时需要考虑这些变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号